BioSpace News Archive

Phase II trial evaluating bemcentinib in combination with low-dose cytarabine (LDAC) in elderly AML patients unfit for intensive therapy is well tolerated and shows promising efficacy

Dova Pharmaceuticals, a wholly owned subsidiary of Swedish Orphan Biovitrum AB, presented additional analyses from the phase 3 study - core and extension phase - with avatrombopag for the treatment of immune thrombocytopenia, at the 61st Annual Meeting of the American Society of Hematology taking place in Orlando, 7-10 December.

The collaboration will leverage Healx’s AI technologies and rare disease expertise to advance Boehringer Ingelheim’s drug discovery programme

Achieve Life Sciences, Inc. announced an update on the cytisinicline clinical development program.

326 Physicians, Representing Nearly a Third of the Top 1,000 SNM Implanters in the U.S., Attended Axonics-Sponsored Seminars over the Past Two Months

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and ArQule, Inc. (Nasdaq: ARQL) today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire ArQule for $20 per share in cash for an approximate total equity value of $2.7 billion.

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced that it has scheduled a company presentation at Biotech Showcase 2020, to be held January 13-15, 2020 during the most important week in healthcare.

CYC065-venetoclax combination was well tolerated in AML and CLL dose escalation studies

At the 2019 joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), Bruker (Nasdaq: BRKR) today announced the launch of the Luxendo TruLive3D Imager light-sheet imaging system.

Antios Therapeutics, Inc. (“Antios”), a biopharmaceutical company focused on the development of innovative therapies to treat and cure viral diseases, today announced the acceptance of an oral presentation at the 23rd biennial HEP DART meeting being held December 8-12, 2019 in Kauai, Hawaii.